ResearcherFirst Affiliated Hospital of Wenzhou Medical UniversityNo recent work listed

Kang Yu

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers: 0
Trials: 1 (principal investigator on 1)
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2017: 1 trial

Trials 1

Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors Principal investigator NCT03302403 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mengtao Zhou · 1 shared trial, 2017 · strength 0.17
- Trial Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors NCT03302403 ↗
Songfu Jiang · 1 shared trial, 2017 · strength 0.17
- Trial Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors NCT03302403 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.